331
Views
0
CrossRef citations to date
0
Altmetric
Commentary

The PD-1/PD-L1 Axis in the Pathogenesis of Urothelial Bladder Cancer and Evaluating its Potential as a Therapeutic Target

, , , , , , , , & show all
Pages 595-600 | Received 26 Oct 2015, Accepted 24 Nov 2015, Published online: 01 Feb 2016
 

Financial & competing interests disclosure

P Patel has been paid speaker fees by Astellas and Roche. ND James has contributed to advisory boards for Merck USA and Pierre Fabre. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.